Jiawei Chai
Overview
Explore the profile of Jiawei Chai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang M, Chen X, Cheng C, Yan W, Guo R, Wang Y, et al.
Phytomedicine
. 2024 Apr;
129:155548.
PMID: 38583347
Background: Oral leukoplakia (OLK), characterized by abnormal epithelial hyperplasia, is the most common precancerous oral mucosa lesion and is closely related to oxidative stress. Cucurbitacin B (CuB), a tetracyclic triterpenoid...
2.
Saneyasu T, Ueda M, Nagata K, Chai J, Honda K, Kamisoyama H
J Poult Sci
. 2022 Nov;
59(4):357-363.
PMID: 36382057
Previous studies in mammalian obesity models have suggested that central transforming growth factor- (TGF-) controls the gene expression of appetite-regulating neuropeptides and peripheral energy metabolism. In the present study, we...
3.
Chai J, Kong J, Zhu K
Biomed Res Int
. 2022 Mar;
2022:3970884.
PMID: 35257009
Background: The characteristics and outcomes of patients with intrahepatic cholangiocarcinoma (ICC) with prior malignancy are poorly clarified. This study is aimed at exploring the impact of prior malignancy on the...
4.
Kong J, Yu G, Si W, Li G, Chai J, Liu Y, et al.
BMC Cancer
. 2022 Feb;
22(1):142.
PMID: 35123420
Background: Hepatocellular carcinoma (HCC) is the most common primary liver cancer in the world. Although great advances in HCC diagnosis and treatment have been achieved, due to the complicated mechanisms...
5.
Kong J, Yu G, Si W, Li G, Chai J, Liu Y, et al.
Front Oncol
. 2021 Sep;
11:713637.
PMID: 34497765
Background: Second primary malignancy (SPM) is becoming a threat for the health of cancer survivors. However, data on the features and results of patients with hepatocellular carcinoma (HCC) with SPMs...
6.
Kong J, Li G, Chai J, Yu G, Liu Y, Liu J
Ann Surg Oncol
. 2021 Jun;
28(13):8221-8233.
PMID: 34160708
Background: Controversy exists over the relationship between postoperative complications (POCs) and long-term survival for hepatocellular carcinoma (HCC) after hepatectomy. This study aimed to evaluate the impact of POCs on overall...
7.
Kong J, Li G, Chai J, Yu G, Liu Y, Liu J
Ann Surg Oncol
. 2021 Jun;
28(13):8234-8235.
PMID: 34145503
No abstract available.
8.
Kong J, Cao Y, Chai J, Liu X, Lin C, Wang J, et al.
Front Oncol
. 2021 Feb;
10:559911.
PMID: 33552949
Background: The relationship between tumor size and survival in intrahepatic cholangiocarcinoma (ICC) is still controversial. This study aimed to evaluate the prognostic ability of tumor size for solitary ICC after...